Immunohistochemical detection of proliferating tumor cells in cervical cancer using monoclonal antibody ki-67

Gynecologic and Obstetric Investigation

Volumn 37, Issue 2, 1994, Pages 123-126

  Wong, Felix W S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Ki 67; Monoclonal antibody; Proliferating tumor cells

Indexed keywords

MONOCLONAL ANTIBODY KI 67;

ARTICLE; CELL CYCLE; CELL KINETICS; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MITOSIS RATE; PRIORITY JOURNAL; PROGNOSIS; STAINING; TUMOR GROWTH; UTERINE CERVIX CANCER;

ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CERVIX NEOPLASMS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; NEOPLASM PROTEINS; NUCLEAR PROTEINS;

EID: 0028153631     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000292539     Document Type: Article

References (18)

1. Graem N, Helwag-Larsen K: Mitotic activity and delay in fixation of tumour tissue. Acta Path Microbiol Scand [A] 1979;87:375-378.
2. Hoshino T, Nagashima T, Murovic J, et al: Cell kinetic studies of in situ human brain tumours with bromodeoxyuridine. Cytometry 1985:6: 627-632.
3. Gatter KC, Brown G, Trowbridge IS, et al: Transferrin receptors in human tissues: Their distribution and possible clinical relevance. J Clin Pathol 1983;36:539-545.
4. Gerdes J, Lemke H, Basich H, et al: Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133:1710-1715.
5. Gatter KC, Dunnill MS, Gerdes J, et al: New approach to assessing lung tumours in man. J Clin Pathol 1986;39:590-593.
6. Gerdes J, Lelle RJ, Pickartz H, et al: Growoth fractions in breast cancers determined in situ with monoclonal antibody Ki-67. J Clin Pathol 1986;39:977-980.
7. Gerdes J, Dallenbach F, Lennert K: Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol Oncol 1984;2:365-371.
8. Brown DC, Cole D, Gatter KC, et al: Carcinoma of the cervix uteri: An assessment of tumour proliferation using the monoclonal antibody Ki-67. Br J Cancer 1988:57:178-181.
9. Blaustein A: Pathology of the Female Genital Tract, ed 2. New York, Springer 1982, pp 194-195.
10. Shackney SE, McCormack GW, Cuchural GJ: Growth rate patterns of solid tumours and their relation to responsiveness to therapy. Ann Intern Med 1978;89:107-121.
11. Crissman JD, Budhraja M, Aron BS, et al: Histopathologic prognostic factors in stage II and III squamous cell carcinoma of the uterine cervix. Int J Gynecol Pathol 1978;6:97-103.
12. Stendahl U, Eklund G, Willen R: Prognosis of invasive squamous cell carcinoma of the uterine cervix. A comparative study of the predictive bases of clinical staging IB-II and a histopathologic malignancy grading system. Int Gynecol Pathol 1983:2:42-54.
13. Barber HRK, Sommers SC, Rotterdam H, et al: Vascular invasion as a prognostic factor in stage IB cancer of the cervix. Obstct Gynecol 1978:51:343-348.
14. Chung CK, Nahhas WA, Zaino R, et al: Histologic Grade lymph node metastasis in squamous cell carcinoma of the cervix. Gynecol Oncol 1981:12:348-354.
15. Silverberg SG: Reproducibility of the mitotic count on the histologic diagnosis of smooth muscle tumours of the uterus. Hum Pathol 1976.7:451-454.
16. Fulling KH, Garcia DM: Anaplastic astrocytoma of the adult cerebrum. Prognostic value of histologic features. Cancer 1985;55:928-931.
17. Barnard NJ, Hall PA, Lemoine NR, Kadar N: Proliferative index in breast carcinoma determined in situ by Ki-67 immunostaining and its relationship to clinical and pathological variables. J Pathol 1987;152:287-295.
18. Pastouris E, Stocker U, Kallmeyer V, Keiditsch E, Mehraein P, Stavrou D: Relationship between Ki-67 positive cells, growth rate and histolog.cal type of human intracranial tumors. Anticancer Res 1988:8:537-544.